Browse our anti-RAS Guanyl Releasing Protein 1 (Calcium and DAG-Regulated) (RASGRP1) Antibodies

Mouse (Murine) RAS Guanyl Releasing Protein 1 (Calcium and DAG-Regulated) (RASGRP1) interaction partners

1. guanine nucleotide exchange factor (show ARHGEF12 Antibodies) RasGRP1 inhibited Rhes (show RASD2 Antibodies)-mediated control of striatal motor activity in mice. RasGRP1 stabilized Rhes (show RASD2 Antibodies), increasing its synaptic accumulation in the striatum.

2. signaling underpins thymic selection processes induced by both weak and strong TCR signals and is differentially required for fate decisions derived from a strong TCR stimulus

3. RasGRP1/3-deficient progenitors show impaired migration toward the CCR9 (show CCR9 Antibodies) ligand, CCL25 (show CCL25 Antibodies), suggesting that RasGRP1 and RasGRP3 (show RASGRP3 Antibodies) may regulate progenitor entry into the thymus through a CCR9 (show CCR9 Antibodies)-dependent mechanism.

4. RasGRP1 is indispensable for development of B1a cells with autoantigen receptors, revealing a connection between a signaling molecule and development of a specific repertoire within the B1a cell population

5. Genetic Rasgrp1 depletion from mice with either an activating mutation in KRas or with aberrant Wnt (show WNT2 Antibodies) signalling due to a mutation in Apc (show APC Antibodies) resulted in both cases in exacerbated Ras-ERK (show EPHB2 Antibodies) signalling and cell proliferation.

6. CD44 (show CD44 Antibodies) expression, CD4 (show CD4 Antibodies)(+) T cell subset ratios and serum autoantibodies all returned to normal in Rasgrp1(Anaef)Mtor (show FRAP1 Antibodies)(chino) double-mutant mice

7. RasGRP1 upregulates signaling from Ras and contributes to epidermal tumorigenesis by increasing the total dosage of active Ras.

8. autoreactive B cells lacking Rasgrp1 break central and peripheral tolerance through both T cell-independent and -dependent mechanisms.

9. Dysregulated RasGRP1 responds to cytokine receptor (show LEPR Antibodies) input in T cell leukemogenesis.

10. RasGRP1, but not RasGRP3 (show RASGRP3 Antibodies), is required for thymocyte positive selection and invariant natural killer T cell selection.

Human RAS Guanyl Releasing Protein 1 (Calcium and DAG-Regulated) (RASGRP1) interaction partners

1. The marked differences between RasGRP3 (show RASGRP3 Antibodies) and RasGRP1 in membrane interaction necessarily will contribute to their different behavior in cells.

2. Cytokines IL-2 (show IL2 Antibodies)/7/9 stimulation activates PI3K (show PIK3CA Antibodies)/Akt (show AKT1 Antibodies) pathways downstream of Ras in RasGRP1 T-cell acute lymphoblastic leukemia (T-ALL).

3. results demonstrate the critical role of CalDAG-GEFI in rapid alphaIIbbeta3 activation of human platelets.

4. This study shows that deficiency in RASGRP1 results in a previously unknown primary immunodeficiency disease, and that RASGRP1 plays role in immune cell signaling and function in T cells, B cells and NK cells. It also identifies a previously unknown role for RASGRP1 in the dynamic regulation of the cytoskeleton, and identify lenalidomide as a potpotential treatment option for this immunodeficiency.

5. This study aimed to replicate and verify the association of RASGRP1 tag single-nucleotide polymorphisms with T2D in a Chinese Han population.

6. present a crystal structure of a fragment of RasGRP1 in which the Ras-binding site is blocked by an interdomain linker and the membrane-interaction surface of RasGRP1 is hidden within a dimerization interface

7. A genome-wide association study identifies GRK5 (show GRK5 Antibodies) and RASGRP1 as type 2 diabetes loci in Chinese Hans.

8. This is the first study aimed at evaluating CalDAG-GEFI gene sequences in people with mucocutaneous bleeding of unknown cause.

9. PAQR10 (show MMD2 Antibodies) and PAQR11 (show MMD Antibodies) are able to interact with RasGRP1, a guanine nucleotide exchange protein (show EEF1D Antibodies) of Ras, and increase Golgi localization of RasGRP1. The C1 domain of RasGRP1 is both necessary and sufficient for the interaction of RasGRP1 with PAQR10 (show MMD2 Antibodies)/PAQR11 (show MMD Antibodies).

10. cooperation between aberrant expression of RasGRP1, a strong activator of Ras, and secondary gain-of-function mutations of NOTCH1 (show NOTCH1 Antibodies) have an important role in T-cell leukemogenesis